Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis

Abstract

To identify genes associated with the resistance of Copenhagen (Cop) rats to mammary carcinogenesis, we infused a retrovirus harboring v-Ha-ras directly into the main mammary ducts of resistant F1 rats from a cross between Cop and susceptible Wistar Furth (WF) rats. Adenocarcinomas formed in approximately 50% of infused glands. Cell lines derived from these tumors were clonal, but did not share a common viral integration site, suggesting that a high level of v-Ha-ras expression was able to overcome resistance in the F1 rats. Some of the cell lines were able to grow in soft agar, but a significant number did not display anchorage-independent growth. These growth characteristics were independent of v-Ha-ras expression levels. The ability to grow in soft agar was associated with the size of tumors induced by injecting the cells into nude mice, and showed a striking positive association with the expression of cyclin D1. Furthermore, while resistance to anchorage-independent growth was fully overcome by transfection of cyclin D1 in some clones, in the others the effect was partial. A similar pattern of cyclin D1 upregulation and growth in soft agar was also observed when the cells were transfected with an active form of β-catenin. Hybrid cells from the somatic fusion of an anchorage-dependent to an anchorage-independent clone did not grow in soft agar. These results suggest that while a high expression level of cyclin D1 is necessary for anchorage-independent growth in all clones, it is not sufficient for full growth capacity in soft agar, raising the possibility that the loss of a tumor suppressor gene in the cell lines is required to fully confer anchorage-independent growth. Our anchorage-dependent and -independent rat mammary tumor-derived cell lines may recapitulate the resistance and susceptibility of Cop and WF rats, respectively, to mammary carcinogenesis that could facilitate the identification of breast cancer susceptibility genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bani MR, Rak J, Adachi D, Wiltshire R, Trent JM, Kerbel RS and Ben-David Y . (1996). Cancer Res., 56, 3075–3086.

  • Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R and Birchmeier W . (1996). Nature, 382, 638–642.

  • Ben-David Y, Giddens EB and Bernstein A . (1990a). Proc. Natl. Acad. Sci. USA, 87, 1332–1336.

  • Ben-David Y, Lavigueur A, Cheong GY and Bernstein A . (1990b). N. Biol., 2, 1015–1023.

  • Bestwick RK, Hankins WD and Kabat D . (1985). J. Virol., 56, 660–664.

  • Espada J, Perez-Moreno M, Braga VM, Rodriguez-Viciana P and Cano A . (1999). J. Cell Biol., 146, 967–980.

  • Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL and Conti CJ . (1994). Oncogene, 9, 3627–3633.

  • Frisch SM and Francis H . (1994). J. Cell Biol., 124, 619–626.

  • Gould MN, Wang B and Moore CJ . (1989). Genes and Signal Transduction in Multistage Carcinogenesis, Colbrun NH (ed). Marcel Dekker: New York, pp. 19–38.

    Google Scholar 

  • Han EK, Sgambato A, Jiang W, Zhang YJ, Santella RM, Doki Y, Cacace AM, Schieren I and Weinstein IB . (1995). Oncogene, 10, 953–961.

  • Jiang W, Kahn SM, Zhou P, Zhang Y, Cacace AM, Infante A, Doi S, Santella RM and Weinstein IB . (1993). Oncogene, 8, 3447–3457.

  • Korkola JE and Archer MC . (1999). Carcinogenesis, 20, 221–227.

  • Korkola JE, Wood GA and Archer MC . (1999). Breast Cancer Res., 1, 88–94.

  • Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG and Hung MC . (2000). Proc. Natl. Acad. Sci. USA, 97, 4262–4266.

  • Markowitz D, Goff S and Bank A . (1988). J. Virol., 62, 1120–1124.

  • Michaelson JS and Leder P . (2001). Oncogene, 20, 5093–5099.

  • Miller JR and Moon RT . (1996). Genes Dev., 10, 2527–2539.

  • Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW . (1997). Science, 275, 1787–1790.

  • Peters G . (1990). Cell Growth Differ., 1, 503–510.

  • Polakis P . (1999). Curr. Opin. Genet. Dev., 9, 15–21.

  • Price JE, Polyzos A, Zhang RD and Daniels LM . (1990). Cancer Res., 50, 717–721.

  • Quaroni A and Isselbacher KJ . (1981). J. Natl. Cancer Inst., 67, 1353–1362.

  • Rak J, Mitsuhashi Y, Erdos V, Huang S-N and Kerbel RS . (1995). J. Cell Biol., 131, 1587–1598.

  • Rosen K, Rak J, Leung T, Dean NM, Kerbel RS and Filmus J . (2000). J. Cell Biol., 149, 447–456.

  • Rudland PS, Paterson FC, Monaghan P, Davies AC and Warburton MJ . (1986). Dev. Biol., 113, 388–405.

  • Russo J and Russo IH . (2000). J. Mammary Gland. Biol. Neoplasia, 5, 187–200.

  • Shepel LA, Lan H, Haag JD, Brasic GM, Gheen ME, Simon JS, Hoff P, Newton MA and Gould MN . (1998). Genetics, 149, 289–299.

  • Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A . (1999). Proc. Natl. Acad. Sci. USA, 96, 5522–5527.

  • Sukumar S, Notario V, Martin-Zanca D and Barbacid M . (1983). Nature, 306, 658–661.

  • Teodori L, Tagliaferri F, Stipa F, Valente MG, Coletti D, Manganelli A, Guglielmi M, D'Angelo LS, Schafer H and Gohde W . (2000). In Vitro Cell Dev. Biol. Anim., 36, 153–162.

  • Tetsu O and McCormick F . (1999). Nature, 398, 422–426.

  • Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ and Gould MN . (1991). Cancer Res., 51, 5298–5303.

  • Willert K and Nusse R . (1998). Curr. Opin. Genet. Dev., 8, 95–102.

  • Wood GA, Korkola JE and Archer MC . (2002). Carcinogenesis, 23, 1–9.

  • Wisdom R, Johnson RS and Moore C . (1999). EMBO J., 18, 188–189.

  • Zhou Q, Hopp T, Fuqua SAW and Steeg PS . (2001). Cancer Lett., 162, 3–17.

  • Zhou Q, Wulfkuhle J, Ouatas T, Fukushima P, Stetler-Stevenson M, Miller FR and Steeg PS . (2000). Breast Cancer Res. Treat., 59, 27–39.

Download references

Acknowledgements

We thank Dr B Vogelstein for the β-catenin plasmid and Dr IB Weinstein for the cyclin D1 plasmid. We also thank Drs J Filmus and Kirill Rosen for their constructive comments on the manuscript and Robin Duncan for help with the experiments with nude mice. This work was supported by a grant from the Canadian Breast Cancer Research Initiative.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yaacov Ben-David.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, YJ., Song, R., Korkola, J. et al. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis. Oncogene 22, 3452–3462 (2003). https://doi.org/10.1038/sj.onc.1206411

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206411

Keywords

This article is cited by

Search

Quick links